000			01648nam a2200193Ia 4500
003			MX-MdCICY
005			20250625124734.0
040			_cCICY
090			_aB-9166
245	1	0	_aThe value of natural products to future pharmaceutical discovery
490	0		_vNatural Product Reports, 24(6), p.1225-1244, 2007
520	3		_aNatural products have provided considerable value to the pharmaceutical industry over the past half century. In particular, the therapeutic areas of infectious diseases and oncology have benefited from numerous drug classes derived from natural product sources. Unfortunately, pharmaceutical companies have significantly decreased activities in natural product discovery during the past several years. Biotechnology companies working in the fields of combinatorial biosynthesis, genetic engineering and metagenomic approaches to identify novel natural product lead molecules have had limited success. Despite what appears to be a slow death of natural product discovery research, many new and interesting molecules with biological activity have been published in the past few years. If natural product materials continue to be tested for desirable therapeutic activities, we believe that significant progress in identifying new antibiotics, oncology therapeutics and other useful medicines will be made.
700	1	2	_aBaker, D. D.
700	1	2	_aChu, Min
700	1	2	_aRajgarhia, V.
856	4	0	_uhttps://drive.google.com/file/d/1obRoqWdXJAZ5C6okFpb1SjmPZkYJpPkE/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx
942			_2Loc _cREF1
008			250602s9999 xx |||||s2 |||| ||und|d
999			_c43423 _d43423